GlassScriptPhysician profile
Michael A Gaglia
NPI 1528031663
$13,550.50
in general payments reported to CMS, 2019-2025
38 companies · $1,550 in 2025
The $1,550 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,073 · 2020: $1,835 · 2021: $928 · 2022: $1,844 · 2023: $1,233 · 2024: $1,087 · 2025: $1,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,869.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $4,178.02 | 2019 | |
| Medtronic Vascular, INC. | $1,345.97 | 2020 | |
| Boston Scientific Corporation | $951.52 | 2019-2025 | Eluvia, Angiojet Ultra 5000a, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $917.62 | 2021-2023 | Corevalve Evolut R, Hawkone |
| Cardiovascular Systems INC. | $907.04 | 2019-2023 | Diamondback Coronary |
| Stryker Corporation | $655.87 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $541.92 | 2020-2024 | Glidesheath Slender |
| Inari Medical, INC. | $398.65 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $355.06 | 2020-2024 | Impella |
| Heartflow, INC. | $343.40 | 2025 | |
| Janssen Pharmaceuticals, INC | $293.97 | 2020-2023 | Xarelto |
| Shockwave Medical, INC | $282.41 | 2024-2025 | Shockwave Medical L6 Intravascular Lithotripsy (Ivl) Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+ |
| Abbott Laboratories | $254.51 | 2019-2024 | Diamondback Coronary, Diamondback Peripheral |
| Edwards Lifesciences Corporation | $250.93 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $249.74 | 2019-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gaglia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.